Global Type1 Diabetes Market Research and Forecast 2018-2023
Global type1 diabetes market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, and Forecast 2018-2023
Global Type1 Diabetes Market The global type1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. Type1 diabetes is a serious, chronic condition that is caused when insulin is not created within the body, making the glucose level too high. It is the condition when cells that make insulin are attacked and destroyed by the body, it causes type1 diabetes. Out of all the diabetic patients, only 5% have type1 diabetes.
Global Type1 Diabetes Market The growth of the market is also dependent on technological advancement in the insulin delivery and rising demand for minimally invasive and non-invasive insulin delivery. The other factors contributing to the growth of the market include cohesive government policies, initiatives and programs for the type1 diabetes. Apart from this, increasing chronic diseases associated with diabetes are contributing significantly to the growth of the market.
Global Type1 Diabetes Market However, certain factors such as high cost of the diagnosis and treatment therapies for diabetes may hamper the growth of global type1 diabetes market. Geographically, the global type1 diabetes market has been divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global type1 diabetes market due to technological advancements and supportive government initiatives in this region. APAC is anticipated to be the most emerging market due to increasing number of diabetics due to obesity, geriatric population, and changing lifestyles of the people.
Global Type1 Diabetes Market The companies contributing to the growth of global type1 market includes Abbott Laboratories, Bayer AG, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Ltd., Merck & C0., and Pfizer Inc. Majority of the players are adopting various strategies such as mergers and acquisitions or entering into strategic alliance with other major players from the market in order to gain a competitive edge over others and enhance their presence.
Research Methodology The market study of type1 diabetes market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate.
Research Methodology The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data.
Research Methodology This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports. Related Reports: Healthcare Industry Research
Secondary sources include • Financial reports of companies involved in the market • Whitepapers, research-papers and news blogs • Company websites and their product catalogue The report is intended for hospitals, diagnostic centers, Laboratories, universities, private and government organizations for the overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers.
Table Of Content CHAPTER 1. REPORT SUMMARY 1.1. RESEARCH METHODS AND TOOLS 1.2. MARKET BREAKDOWN 1.2.1. BY SEGMENTS 1.2.2. BY GEOGRAPHY 1.2.3. BY STAKEHOLDERS
Table Of Content CHAPTER 2. MARKET OVERVIEW AND INSIGHTS 2.1. DEFINITION 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS 2.2.1. KEY FINDINGS 2.2.2. RECOMMENDATION 2.2.3. CONCLUSION 2.3. REGULATIONS 2.3.1. UNITED STATES 2.3.2. EUROPEAN UNION 2.3.3. CHINA 2.3.4. INDIA 2.3.5. REST OF THE WORLD
Table Of Content CHAPTER 3. MARKET DETERMINANT 3.1. MOTIVATORS 3.1.1. INCREASING CHRONIC DISEASES ASSOCIATED WITH DIABETES 3.1.2. RISING DEMAND FOR NON-INVASIVE MONITORING DEVICES 3.1.3. GROWING WEARABLE DEVICES FOR MONITORING 3.1.4. INCREASING GOVERNMENT INITIATIVES 3.2. RESTRAINTS 3.2.1. HIGH COST OF DIAGNOSIS AND TREATMENT 3.2.2. LACK OF AWARENESS IN EMERGING ECONOMIES 3.3. OPPORTUNITIES 3.3.1. RISING DIABETES PATIENTS IN APAC REGION
Table Of Content CHAPTER 4. MARKET SEGMENTATION 4.1. GLOBAL TYPE1 DIABETES MARKET BY INSULIN ANALOG 4.1.1. RAPID-ACTING 4.1.2. LONG-ACTING 4.1.3. PREMIX 4.2. GLOBAL TYPE1 DIABETES MARKET BY DRUG CLASS 4.2.1. INSULIN 4.2.2. OTHERS 4.3. GLOBAL TYPE1 DIABETES MARKET BY DEVICES 4.3.1. INSULIN PUMPS 4.3.2. INSULIN PEN 4.3.3. BLOOD GLUCOSE METERS 4.3.4. OTHERS
Table Of Content CHAPTER 5. COMPETITIVE LANDSCAPE 5.1. STRATEGY ANALYSIS 5.2. KEY COMPANY ANALYSIS CHAPTER 6. REGIONAL ANALYSIS 6.1. NORTH AMERICA 6.1.1. UNITED STATES 6.1.2. CANADA 6.2. EUROPE 6.2.1. UNITED KINGDOM 6.2.2. FRANCE 6.2.3. GERMANY
Table Of Content 6.2.4. ITALY 6.2.5. SPAIN 6.2.6. REST OF EUROPE 6.3. ASIA PACIFIC 6.3.1. INDIA 6.3.2. CHINA 6.3.3. JAPAN 6.4. REST OF THE WORLD
Orion Market Research
CONTACT US Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010
+1-646-755-7667 +91-7803040404 info@omrglobal.com www.omrglobal.com/
https://www.omrglobal.com/industry-reports/type1-diabetes-market/